Adiponectin: A Predictor for Breast Cancer Survival? | Zendy

Hikmet Erhan Güven | Zendy; Lütfi Doğan | Zendy; Mehmet Ali Gülçelik | Zendy; Neşe Ersöz Gülçelik | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adiponectin: A Predictor for Breast Cancer Survival?

Author(s) -

Hikmet Erhan Güven,

Lütfi Doğan,

Mehmet Ali Gülçelik,

Neşe Ersöz Gülçelik

Publication year - 2018

Publication title -

meme sağlığı dergisi/meme sağlığı dergisi

Language(s) - English

Resource type - Journals

eISSN - 1306-0953

pISSN - 1306-0945

DOI - 10.5152/ejbh.2018.4349

Subject(s) - adiponectin , breast cancer , oncology , medicine , cancer , obesity , insulin resistance

Breast cancers in women with low serum adiponectin levels have been reported to show phenotypes that are more aggressive. In 2008, we investigated the relationship between serum adiponectin levels and breast cancer in our case-controlled study involving 83 patients, in which serum adiponectin levels were measured preoperatively. In this study, we aimed to investigate the relationship between serum adiponectin levels and breast cancer-specific survival among these 83 patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research